GXH Stock Overview
Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand.
Green Cross Health Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||NZ$1.30|
|52 Week High||NZ$1.50|
|52 Week Low||NZ$1.04|
|1 Month Change||-5.80%|
|3 Month Change||5.69%|
|1 Year Change||23.81%|
|3 Year Change||13.04%|
|5 Year Change||-42.73%|
|Change since IPO||170.83%|
Recent News & Updates
Capital Allocation Trends At Green Cross Health (NZSE:GXH) Aren't Ideal
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Green Cross Health (NZSE:GXH) Share Prices Have Dropped 58% In The Last Five Years
The main aim of stock picking is to find the market-beating stocks. But even the best stock picker will only win with...
|GXH||NZ Consumer Retailing||NZ Market|
Return vs Industry: GXH exceeded the NZ Consumer Retailing industry which returned -7.6% over the past year.
Return vs Market: GXH exceeded the NZ Market which returned -13.1% over the past year.
|GXH Average Weekly Movement||5.2%|
|Consumer Retailing Industry Average Movement||4.1%|
|Market Average Movement||4.1%|
|10% most volatile stocks in NZ Market||7.7%|
|10% least volatile stocks in NZ Market||2.8%|
Stable Share Price: GXH is not significantly more volatile than the rest of NZ stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: GXH's weekly volatility (5%) has been stable over the past year.
About the Company
Green Cross Health Limited provides health support, care, and advice services to communities in New Zealand. It operates in three segments: Pharmacy Services, Medical Services, and Community Health. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores.
Green Cross Health Fundamentals Summary
|GXH fundamental statistics|
Is GXH overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|GXH income statement (TTM)|
|Cost of Revenue||NZ$541.39m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.12|
|Net Profit Margin||2.91%|
How did GXH perform over the long term?See historical performance and comparison
4.6%Current Dividend Yield
Is Green Cross Health undervalued compared to its fair value and its price relative to the market?
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GXH (NZ$1.3) is trading below our estimate of fair value (NZ$3.58)
Significantly Below Fair Value: GXH is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GXH is good value based on its Price-To-Earnings Ratio (10.6x) compared to the Oceanic Consumer Retailing industry average (16.9x).
PE vs Market: GXH is good value based on its Price-To-Earnings Ratio (10.6x) compared to the NZ market (16.9x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate GXH's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: GXH is good value based on its Price-To-Book Ratio (1.2x) compared to the XO Consumer Retailing industry average (3.7x).
How is Green Cross Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Consumer Retailing industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Green Cross Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Green Cross Health performed over the past 5 years?
Past Performance Score3/6
Past Performance Score 3/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GXH has high quality earnings.
Growing Profit Margin: GXH's current net profit margins (2.9%) are higher than last year (2.7%).
Past Earnings Growth Analysis
Earnings Trend: GXH's earnings have declined by 3.7% per year over the past 5 years.
Accelerating Growth: GXH's earnings growth over the past year (14.6%) exceeds its 5-year average (-3.7% per year).
Earnings vs Industry: GXH earnings growth over the past year (14.6%) underperformed the Consumer Retailing industry 43.2%.
Return on Equity
High ROE: GXH's Return on Equity (14.3%) is considered low.
How is Green Cross Health's financial position?
Financial Health Score5/6
Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: GXH's short term assets (NZ$114.1M) do not cover its short term liabilities (NZ$119.3M).
Long Term Liabilities: GXH's short term assets (NZ$114.1M) exceed its long term liabilities (NZ$93.7M).
Debt to Equity History and Analysis
Debt Level: GXH has more cash than its total debt.
Reducing Debt: GXH's debt to equity ratio has reduced from 63% to 16.4% over the past 5 years.
Debt Coverage: GXH's debt is well covered by operating cash flow (188.4%).
Interest Coverage: GXH's interest payments on its debt are well covered by EBIT (6.1x coverage).
What is Green Cross Health current dividend yield, its reliability and sustainability?
Dividend Score 2/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: GXH's dividend (4.62%) is higher than the bottom 25% of dividend payers in the NZ market (3.12%).
High Dividend: GXH's dividend (4.62%) is low compared to the top 25% of dividend payers in the NZ market (5.68%).
Stability and Growth of Payments
Stable Dividend: GXH's dividend payments have been volatile in the past 10 years.
Growing Dividend: GXH's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: Unable to calculate sustainability of dividends as GXH has not reported any payouts.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (19.5%), GXH's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Ms. Rachael Newfield has been the Group Chief Executive Officer of Green Cross Health Limited since January 2019.
Experienced Management: GXH's management team is considered experienced (3.8 years average tenure).
Experienced Board: GXH's board of directors are considered experienced (7.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Green Cross Health Limited's employee growth, exchange listings and data sources
- Name: Green Cross Health Limited
- Ticker: GXH
- Exchange: NZSE
- Founded: 1999
- Industry: Drug Retail
- Sector: Consumer Retailing
- Implied Market Cap: NZ$186.099m
- Shares outstanding: 143.15m
- Website: https://www.greencrosshealth.co.nz
Number of Employees
- Green Cross Health Limited
- Building B
- Ground Floor
- New Zealand
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/25 00:00|
|End of Day Share Price||2022/05/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.